Lavi Erisson

Lavi Erisson is a highly accomplished professional with a diverse background in business, public policy, and medicine, specializing in innovating healthcare solutions to improve patient outcomes.

He holds an MBA in Business Administration and Management from Massachusetts Institute of Technology, a Master of Public Policy in Public Policy (Magna Cum Laude) from Tel Aviv University, and received medical training from Tel Aviv University as well.

Currently, Lavi serves as the CEO and Co-Founder of M13 Therapeutics, leading the company in its mission to make meaningful contributions to the field of healthcare.

His previous roles include Chief Strategy Officer and Chief Commercial & Clinical Officer at Iterative Scopes, where he played vital roles in shaping the strategic direction and operational efficiency of the organization.

Additionally, Lavi has a rich history of leadership positions such as being a MIT Sloan Fellow, CEO & Founder of Codega, LLC, Vice President of Life Sciences at Landmark Ventures, and holding roles in public health research and advisory capacities.

He has also contributed significantly to the industry through various consulting roles in strategy and R&D within biotech and pharma companies.

Lavi Erisson's expertise extends into the realm of translational medicine, corporate venture, and life sciences, having worked at esteemed organizations like Teva Pharmaceuticals and the Israeli Foreign Trade Administration.

With a background in academia, Lavi has also shared his knowledge as a lecturer at Tel Aviv University, focusing on medicine and nurturing science-oriented youth.

His holistic education, extensive experience across different sectors, and commitment to improving healthcare make Lavi Erisson a prominent figure in the field of life sciences and business innovation.